Company Directory / research

PrivateFor profitresearchWilmington, United States
NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.
Size
11-50 people: larger than 33% of companies with a size listed
Age
9 years old.
Reach
Website ranked #3,929,725 in the world for traffic, about 3k visits a month.
BiotechnologyHealth CareMedicalOncology
Funding, as listed
$260M currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about NiKang Therapeutics, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
NiKang Therapeutics may be growing as evidenced by a new collaboration agreement with Roche, a Swiss pharmaceutical giant, to study a deadly liver cancer. This partnership could indicate an expansion of NiKang's research and development capabilities and potential revenue streams. Additionally, the company's presence in news sources suggests an active role in the biotechnology and oncology sectors, which may contribute to its visibility and growth within the industry.
Summaries written by the source dataset, not by us, and not checked.
research in United States.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.